| 000 | 01535cam a2200313 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223031757.0 | ||
| 008 | 170816s2014 ua dh f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aGift | ||
| 097 | _aM.Sc | ||
| 099 | _aCai01.34.M.Sc.2014.Ba.S | ||
| 100 | 0 | _aBasma Mohamed Kamal Elshenawy | |
| 245 | 1 | 2 |
_aA Study on sustanined ocular delivery of netamycin / _cBasma Mohamed Kamal Elshenawy ; supervised Nagia Nagib Afifi |
| 246 | 1 | 5 | _aدراسة عن إطالة مفعول الناتاميسين في العين |
| 260 |
_aCairo : _bBasma Mohamed Kamal Elshenawy , _c2014 |
||
| 300 |
_a121 Leaves : _bcharts , facsimiles ; _c30cm |
||
| 502 | _aThesis (M.Sc.) - Garman University - Faculty of postgraduate studies and scientific research - Department of Pharmaceutical Technology | ||
| 520 | _aFungal keratitis is one of the sight threatening infections. It is second reason of corneal blindness, only preceded by cataract as ststed by the World Health Irganization (WHO). One of the most effective treatment options is topical natamycin suspension. This suspension has the disadvantage of frequent instillation that results in poor patient comliance and consequently poor treatment outcome. | ||
| 653 | 4 | _aFungal keratitis | |
| 653 | 4 | _aNetamycin | |
| 653 | 4 | _aOcular delivery | |
| 700 | 0 |
_aNagia Nagib Afifi , _esupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aNazla _eRevisor |
||
| 905 |
_aShimaa _eCataloger |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c62015 _d62015 |
||